We’re delighted to share that our commitment to advancing Drug Discovery has earned us a spot in the “Top Ten Most Popular Drug Hunter Resources of 2023.”
The insightful article, “Drug Target Identification Methods After a Phenotypic Screen,” published in May 2023, and crafted by the esteemed Drug Hunter team, emerges as an invaluable resource for professionals seeking insights in the dynamic field of Drug Discovery.
“In collaboration with Pelago Bioscience, our minireview encapsulates a wealth of knowledge on identifying a drug’s target when it’s unknown at the outset. Delving into target deconvolution methods employed in the industry, we highlight the strengths and limitations of commonly used approaches. Moreover, we shed light on the utility of label-free methods such as CETSA® for probeless target deconvolution.”
Who Should Read?
For teams that have just completed a phenotypic screening campaign, navigated through hit triage to clean out false positives, and now find themselves with modestly optimized validated leads with cell-based activity, but without a clear understanding of how their compounds work or the worth of pursuing specific targets—this article is tailor-made for you!
Does this sound familiar? Then dive into the full article on Drug Target Identification Methods After a Phenotypic Screen at Drug Hunter.
Unlock the insights that can propel your drug discovery journey! 💡🔍